Back to results
US 2023/0398205 A1Published application
Sars-cov-2 immunodominant peptide constructs and uses thereof
AssigneesTScan Therapeutics, Inc., AHS Hospital Corp.
InventorsTomasz KULA, Gavin MacBeath, Andrew P. Ferretti
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for the treatment and/or prevention of COVID-19 through the induction of an immune response against identified SARS-COV-2 immunodominant peptides.
Claims93
An immunogenic polypeptide comprising at least two peptide epitopes selected from Table 1A, 1B, 1C, 1D, 1E, and/or 1F.
Dependencies are inferred from the claim text.